Theravance Biopharma TBPH Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on the most recent quarter.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's current ratio?
- Theravance Biopharma (TBPH) reported current ratio of 13.1× in Q1 2026.
- How has Theravance Biopharma's current ratio changed year-over-year?
- Theravance Biopharma's current ratio increased by 175.5% year-over-year, from 4.8× to 13.1×.
- What is the long-term trend for Theravance Biopharma's current ratio?
- Over 5 years (2020 to 2025), Theravance Biopharma's current ratio has grown at a 28.0% compound annual growth rate (CAGR), from 3.2× to 10.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.